ELSEVIER

Adenovirus, (33) 89 Immunoblot, (33) 55 Adenovirus type 41, (33) 179 I~unofluores~n~, (33) 55 African horsesickness virus, (33) 157 Infectious RNA transcript, (33) 281 Anficarsia gemmatalk, (33) 99 Invertebrate iridescent virus, (33) 99 Antigenic diversity, (33) 39 Iridoviridae, (33) 99

Virus Research 33 (1994) 295-296

V irus Research

Baculovirus vector, (33) 123 BBLMV, (33) 145 Bfuetongue virus, (33) 11, (33) 139 Border disease virus, (33) 219 Boma disease, (33) 261

Calcium oscillation, (33) 229 Cell fusion, (33) 123 Characterization, (33) 99 Cla~ifi~a~on, (33) 99 Cloning, (33) 167 Coat protein, (33) 145 Cold-adaptation, (33) 241 Complementation, (33) 269 Coxsackievirus, (33) 229

Diabetes mehitus, (33) 229 DNA sequencing, (33) 179

ElA, (33) 89 E2A, (33) 89 Echovirus, (33) 229 Evolutionary relationships, (33) 157 Expression vector pMak2, (33) 55

G glycoprotein, (33) 203 Glucose, (33) 229

Hantavirus, (33) 27 Herpes simplex virus, (33) 67 Herpesviridae, (33) 55 Human Immunodeficency Virus, (33) 269

Subject Index

Lepidoptera, (33) 99 Long terminal repeat sequence, (33) 167

Madin Darby canine kidney cell, (33) 261 Maltose-binding protein, (33) 55 Molecular relationship, (33) 27 Mouse mammary tumor virus, (33) 167 Mutant, (33) 89

Nepovirus, (33) 145 Neutralisation, (33) 11 Neutralization, (33) 139 Newcastle disease virus, (33) 123 3’ Non-coding region, (33) 145 Nucleotide sequence heterogeneity, (33) 203

Ovine pestivirus genome, (33) 219

Pancreatic P-cell, (33) 229 Pestivirus, (33) 219 PoIymerase chain reaction, (33) 39, (33) 55, (33)

157 Positive-strand RNA virus, (33) 39 Protease factor Xa, (33) 55 Protective antibody, (33) 11 Pseudorecombinant, (33) 281

R~mbination, (33) 145 Respiratory syncytial virus, (33) 203, (33) 241 Reverse transcription, (33) 39

296 Subject Index / virus Research 33 (1994) 295-296

Segment 10, (33) 157 Seoul virus, (33) 27 Sequence, (33) 139 Serum-virus neutralization, (33) 39 Strain comparison, (33) 27 Subcloning, (33) 167

Tomato aspermy cucumovirus, (33) 281 Transcription, (33) 89 TS mutant, (33) 241

Vaccine, (33) 11, (33) 241 uif, (33) 269 Viral replication, (33) 67 VP2, (33) 11 VP5, (33) 11 VP2, (33) 139 VPl9c capsid protein, (33) 67

Western blot, (33) 39